Amyloid-Peptide Vaccinations Reduce β-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer’s Transgenic Mice

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012 · see citing works

Microglia-specific localisation of a novel calcium binding protein, Iba1

Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · see citing works

Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial

Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000159740.16984.3c · Cited by 1,329 · see citing works

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease

Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa‐Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,093 · see citing works

Inflammatory processes in Alzheimer's disease

Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782 · see citing works

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773 · see citing works

Optic-Nerve Degeneration in Alzheimer's Disease

Hinton, D. R., Sadun, A. A., Blanks, J. C., & Miller, C. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150804 · Cited by 700 · see citing works

The Aging Brain

Yankner, B. A., Lu, T., & Loerch, P. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.092044 · Cited by 677 · see citing works

Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology

Carare, R. O., Bernardes‐Silva, M., Newman, T. A., Page, A. M., Nicoll, J. A. R., Perry, V. H., & Weller, R. O. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00926.x · Cited by 665 · see citing works

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649 · see citing works

Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205

Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608 · see citing works

Retinal Abnormalities in Early Alzheimer’s Disease

Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W., & Schepens, C. L. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1029 · Cited by 505 · see citing works

Relationship between Cognitive Impairment and Retinal Morphological and Visual Functional Abnormalities in Alzheimer Disease

İşeri, P., Altıntaş, Ö., Tokay, T., & Yüksel, N. (2006) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000204645.56873.26 · Cited by 400 · see citing works

Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease

Goldstein, L. E., Muffat, J., Cherny, R. A., Moir, R. D., Ericsson, M., Huang, X., Mavros, C., Coccia, J. A., Faget, K. Y., Fitch, K. A., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12981-9 · Cited by 366 · see citing works

Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease

Paquet, C., Boissonnot, M., Roger, F., Dighiero, P. L., Gil, R., & Hugon, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.090 · Cited by 353 · see citing works

Morphological and functional retinal impairment in Alzheimer's disease patients

Parisi, V., Restuccia, R., Fattapposta, F., Mina, C., Bucci, M. G., & Pierelli, F. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00620-4 · Cited by 344 · see citing works

Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain

Boche, D., Zotova, E., Weller, R. O., Love, S., Neal, J. W., Pickering, R. M., Wilkinson, D., Holmes, C., & Nicoll, J. A. R. (2008) · Brain · doi:10.1093/brain/awn261 · Cited by 316 · see citing works

Amyloid-β Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease

Ning, A., Cui, J., To, E., Ashe, K. H., & Matsubara, J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-1849 · Cited by 303 · see citing works

Retinal ganglion cell degeneration in Alzheimer's disease

Blanks, J. C., Hinton, D. R., Sadun, A. A., & Miller, C. A. (1989) · Brain Research · doi:10.1016/0006-8993(89)90653-7 · Cited by 297 · see citing works

Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.

McKinnon, S. J., Lehman, D. M., Kerrigan, L. A., Merges, C. A., Pease, M. E., Kerrigan, D., Ransom, N. L., Tahzib, N. G., Reitsamer, H. A., Levkovitch-Verbin, H., et al. (2002) · PubMed · Cited by 296 · see citing works

Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL

Blanks, J. C., Schmidt, S. Y., Torigoe, Y., Porrello, K. V., Hinton, D. R., & Blanks, R. H. I. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00009-7 · Cited by 287 · see citing works

Role of the β‐amyloid protein in Alzheimer's disease

Sisodia, S. S., & Price, D. L. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896005 · Cited by 262 · see citing works

Cerebral amyloid angiopathy

Greenberg, S. M. (1998) · Neurology · doi:10.1212/wnl.51.3.690 · Cited by 245 · see citing works

β-Amyloid Deposition and Functional Impairment in the Retina of the APPswe/PS1ΔE9 Transgenic Mouse Model of Alzheimer’s Disease

Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J., & Xu, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2384 · Cited by 231 · see citing works

Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease

Yankner, B. A., & Lu, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800018200 · Cited by 225 · see citing works

Assessment of Visual Impairment in Patients With Alzheimer's Disease

Sadun, A. A., Borchert, M., DeVita, E., Hinton, D. R., & Bassi, C. J. (1987) · American Journal of Ophthalmology · doi:10.1016/0002-9394(87)90001-8 · Cited by 224 · see citing works

Immunotherapeutic Approaches to Alzheimer's Disease

Monsonego, A., & Weiner, H. L. (2003) · Science · doi:10.1126/science.1088469 · Cited by 217 · see citing works

The Cerebral β-Amyloid Angiopathies: Hereditary and Sporadic

Zhang-Nunes, S., Maat–Schieman, M. L. C., van Duinen, S. G., Roos, R. A. C., Frosch, M. P., & Greenberg, S. M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00559.x · Cited by 195 · see citing works

The influence of visual ability on learning and memory performance in 13 strains of micePreprint

Brown, R. E., & Wong, A. A. (2007) · Learning & Memory · doi:10.1101/lm.473907 · Cited by 186 · see citing works

Ophthalmologic manifestations of Alzheimer's disease

Katz, B., & Rimmer, S. (1989) · Survey of Ophthalmology · doi:10.1016/0039-6257(89)90127-6 · Cited by 180 · see citing works

The amyloidogenic potential and behavioral correlates of stress

Catania, C., Sotiropoulos, I., Silva, R., Onofri, C., Breen, K. C., Sousa, N., & Almeida, O. F. X. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002101 · Cited by 175 · see citing works

Conformation‐Dependent Anti‐Amyloid Oligomer Antibodies

Kayed, R., & Glabe, C. G. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13017-7 · Cited by 165 · see citing works

Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging

Danesh-Meyer, H. V., Birch, H., Ku, J. Y.-F., Carroll, S., & Gamble, G. (2006) · Neurology · doi:10.1212/01.wnl.0000244490.07925.8b · Cited by 164 · see citing works

Optic nerve head and nerve fiber layer in Alzheimer's disease

Tsai, C. S. (1991) · Archives of Ophthalmology · doi:10.1001/archopht.1991.01080020045040 · Cited by 163 · see citing works

Visual loss and getting lost in Alzheimer’s disease

Tetewsky, S. J., & Duffy, C. J. (1999) · Neurology · doi:10.1212/wnl.52.5.958 · Cited by 159 · see citing works

Prevalence of Visual Deficits in Alzheimer's Disease

Mendola, J. D., Cronin‐Golomb, A., Corkin, S., & Growdon, J. H. (1995) · Optometry and Vision Science · doi:10.1002/j.1538-9235.1995.tb03842.x · Cited by 126 · see citing works

Down syndrome and beta-amyloid deposition

Head, E., & Lott, I. T. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00003 · Cited by 125 · see citing works

AβPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576

Carola Otth, L., Concha, I. I., Arendt, T., Stieler, J., Schliebs, R., González-Billault, C. E., & Maccioni, R. B. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4508 · Cited by 119 · see citing works

Neurofibrillary Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein

Masliah, E., Sisk, A., Mallory, M. E., & Games, D. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.357 · Cited by 117 · see citing works

Colour vision deficiencies in Alzheimer's disease

Pache, M. (2003) · Age and Ageing · doi:10.1093/ageing/32.4.422 · Cited by 111 · see citing works

Occurrence of the diffuse amyloid β‐protein (Aβ) deposits with numerous Aβ‐containing glial cells in the cerebral cortex of patients with Alzheimer's disease

Akiyama, H., Mori, H., Saido, T., Kondo, H., Ikeda, K., & McGeer, P. (1999) · Glia · doi:10.1002/(sici)1098-1136(19990215)25:4 · Cited by 103 · see citing works

Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Disease a, b

Wı́sniewski, H. M., VORBRODT, A. W., & WEGIEL, J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48468.x · Cited by 99 · see citing works

Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid

Wilcock, D. M., Jantzen, P. T., Li, Q., Morgan, D., & Gordon, M. N. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.020 · Cited by 95 · see citing works

Correlation Between Aβx-40–, Aβx-42–, and Aβx-43–Containing Amyloid Plaques and Cognitive Decline

Parvathy, S., Davies, P., Haroutunian, V. H., Purohit, D. P., Davis, K. L., Mohs, R. C., Park, H., Moran, T. M., Chan, J. Y., & Buxbaum, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.2025 · Cited by 90 · see citing works

Activated Microglial Cells Are Colocalized With Perivascular Deposits of Amyloid-β Protein in Alzheimer’s Disease Brain

Uchihara, T., Akiyama, H., Kondo, H., & Ikeda, K. (1997) · Stroke · doi:10.1161/01.str.28.10.1948 · Cited by 79 · see citing works

Developmental expression of the Glial fibrillary acidic protein (GFAP) gene in the mouse retina

Sarthy, P. V., Fu, M., & Huang, J. (1991) · Cellular and Molecular Neurobiology · doi:10.1007/bf00741450 · Cited by 76 · see citing works

Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast

Viale, G., Gambacorta, M., Coggi, G., Dell’Orto, P., Milani, M., & Doglioni, C. (1991) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01600164 · Cited by 76 · see citing works

Impaired Visuospatial Recognition Memory but Normal Object Novelty Detection and Relative Familiarity Judgments in Adult Mice Expressing the APPswe Alzheimer's Disease Mutation.

Hale, G., & Good, M. A. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.4.884 · Cited by 66 · see citing works

Vision in dementia: Contrast effects

Lakshminarayanan, V., Lagrave, J., Kean, M. L., Dick, M. B., & Shankle, W. R. (1996) · Neurological Research · doi:10.1080/01616412.1996.11740369 · Cited by 58 · see citing works

β-amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease

Terai, K., Iwai, A., Kawabata, S., Tasaki, Y., Watanabe, T., Miyata, K., & Yamaguchi, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00095-1 · Cited by 58 · see citing works

Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis

Castellani, R. J., Smith, M. A., Perry, G., & Friedland, R. P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.019 · Cited by 57 · see citing works

Brain Aβ amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau

Tomidokoro, Y., Harigaya, Y., Matsubara, E., Ikeda, M., Kawarabayashi, T., Shirao, T., Ishiguro, K., Okamoto, K., Younkin, S. G., & Shoji, M. (2001) · The Journal of Pathology · doi:10.1002/path.897 · Cited by 53 · see citing works

Ocular amyloidosis and secondary glaucoma

Nelson, G. A., Edward, D. P., & Wilensky, J. T. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)00726-5 · Cited by 51 · see citing works

A limited role for microglia in antibody mediated plaque clearance in APP mice

Garcı́a-Alloza, M., Ferrara, B. J., Dodwell, S. A., Hickey, G. A., Hyman, B. T., & Bacskai, B. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.019 · Cited by 46 · see citing works

A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex

Chan, D. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.515 · Cited by 44 · see citing works

Immunohistochemical study of p53-associated proteins in rat brain following lithium–pilocarpine status epilepticus

Tan, Z., Sankar, R., Tu, W., Shin, D. H., Liu, H., Wasterlain, C. G., & Schreiber, S. S. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03360-1 · Cited by 41 · see citing works

Visual-Spatial Deficits Explain Visual Symptoms in Alzheimer's Disease

Butter, C. M., Trobe, J. D., Foster, N. L., & Berent, S. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71969-5 · Cited by 40 · see citing works

Mannan-Abeta28conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice

Petrushina, I., Ghochikyan, A., Mkrtichyan, M., Mamikonyan, G., Movsesyan, N., Ajdari, R., Vasilevko, V., Karapetyan, A., Lees, A., Agadjanyan, M. G., et al. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-42 · Cited by 37 · see citing works

Pattern electroretinogram and luminance electroretinogram in Alzheimer’s disease

Strenn, K., Dal‐Bianco, P., Weghaupt, H., et al. (1991) · Springer eBooks · doi:10.1007/978-3-7091-9135-4_12 · Cited by 34 · see citing works

Lens Defects and Age-Related Fiber Cell Degeneration in a Mouse Model of Increased AβPP Gene Dosage in Down Syndrome

Frederikse, P. H., & Ren, X. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64475-6 · Cited by 34 · see citing works

Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease

Zhou, J., Fonseca, M. I., Kayed, R., Hernandez, I., Webster, S. D., Yazan, O., Cribbs, D. H., Glabe, C. G., & Tenner, A. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-28 · Cited by 33 · see citing works

One‐year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice

Cudennec, C. L., Faure, A., Ly, M., & Delatour, B. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00374.x · Cited by 31 · see citing works

β-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer’s disease

Jung, S. S., Gauthier, S. G., & Cashman, N. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00051-2 · Cited by 31 · see citing works

Early visual impairment is independent of the visuocognitive and memory disturbances in Alzheimer’s disease

Kéri, S., Antal, A., Kálmán, J., Janka, Z., & Benedek, G. (1999) · Vision Research · doi:10.1016/s0042-6989(98)00310-1 · Cited by 25 · see citing works

Visual field loss and Alzheimer’s disease

Whittaker, K., Burdon, M. A., & Shah, P. (2002) · Eye · doi:10.1038/sj/eye/6700037 · Cited by 21 · see citing works

Visual field loss and Alzheimer’s disease

Whittaker, K. W., Burdon, M. A., & Shah, P. (2002) · Eye · doi:10.1038/sj.eye.6700037 · Cited by 18 · see citing works

Alzheimer's Disease, Optic Neuropathy, and Selective Ganglion Cell Damage

Miller, N. R. (1990) · Ophthalmology · doi:10.1016/s0161-6420(90)32624-6 · Cited by 10 · see citing works

The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.

Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466 · see citing works

Parallel findings in age-related macular degeneration and Alzheimer’s disease

Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280 · see citing works

Ocular changes in TgF344-AD rat model of Alzheimer's disease

Tsai, Y., Lu, B., Ljubimov, A. V., Girman, S., Ross-Cisneros, F. N., Sadun, A. A., Svendsen, C. N., Cohen, R. M., & Wang, S. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12888 · Cited by 153 · see citing works

Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease

Krasodomska, K., Lubiński, W., Potemkowski, A., & Honczarenko, K. (2010) · Documenta Ophthalmologica · doi:10.1007/s10633-010-9238-x · Cited by 127 · see citing works

Alzheimer's disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers

Chang, L. Y. L., Lowe, J., Ardiles, A., Lim, J., Grey, A. C., Robertson, K., Danesh‐Meyer, H., Palacios, A. G., & Acosta, M. L. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.004 · Cited by 106 · see citing works

Vascular and metabolic dysfunction in Alzheimer’s disease: a review

Murray, I. V. J., Proza, J. F., Sohrabji, F., & Lawler, J. M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.010355 · Cited by 104 · see citing works

Ocular manifestations of Alzheimer's disease in animal models

Parnell, M., Guo, L., Abdi, M., & Cordeiro, M. F. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/786494 · Cited by 56 · see citing works

Human Islet Amyloid Polypeptide Accumulates at Similar Sites in Islets of Transgenic Mice and Humans

de Koning, E. J. P., Höppener, J. W. M., Verbeek, J. S., Oosterwijk, C., van Hulst, K. L., Baker, C. A., Lips, C. J. M., Morris, J. F., & Clark, A. (1994) · Diabetes · doi:10.2337/diab.43.5.640 · Cited by 42 · see citing works

Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus

Höppener, J. W. M., Jacobs, H. M., Wierup, N., Sotthewes, G., Sprong, M., de Vos, P., Berger, R., Sundler, F., & Åhrén, B. (2008) · Journal of Diabetes Research · doi:10.1155/2008/697035 · Cited by 38 · see citing works

Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model

Höppener, J. W. M., Oosterwijk, C., Nieuwenhuis, M. G., Posthuma, G., Thijssen, J. H. H., Vroom, T. M., Ahrén, B., & Lips, C. J. M. (1999) · Diabetologia · doi:10.1007/s001250051175 · Cited by 153 · see citing works

Human islet amyloid polypeptide transgenic mice as a model of non‐insulin‐dependent diabetes mellitus (NIDDM)

Fox, N. W., Schrementi, J. P., Nishi, M., Ohagi, S., Chan, S. J., Heisserman, J. A., Westermark, G. T., Leckström, A., Westermark, P., & Steiner, D. F. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81444-5 · Cited by 89 · see citing works

Transgenic Mice as a Model for Alzheimers Disease

Lithner, C. U., Hedberg, M. M., & Nordberg, A. K. (2011) · Current Alzheimer Research · doi:10.2174/156720511798192736 · Cited by 34 · see citing works